GRG's Center For Experiential Learning

For ten years, GRG Health has believed that the most valuable healthcare insights don’t come from dashboards alone—but from thoughtful, well-facilitated conversations. As 2025 comes to a close, this reflection looks back on a decade of trust, depth, and human dialogue, and forward to a future where technology supports insight without replacing the nuance that only real conversations can provide.

Advanced melanoma care in the U.S. has evolved rapidly with the rise of immunotherapies, targeted treatments, and precision medicine. Drawing on insights from U.S. oncologists, dermatologists, and payers, this blog examines how clinicians are navigating treatment sequencing, biomarker-driven decisions, and access challenges in real-world practice.

Advanced prostate cancer treatment is shifting from traditional injections to innovative oral hormonal therapies, offering faster testosterone suppression and improved quality of life. This blog explores how personalization and patient-centricity are redefining care, marking a pivotal moment in prostate cancer management.

Systemic Sclerosis care is entering a new era of clinical innovation. This blog explores how recent advances in treatment and disease understanding are improving outcomes, enhancing patient quality of life, and reshaping how clinicians approach this complex autoimmune condition.

Managing Hypophosphatasia (HPP) continues to challenge physicians and patients alike, from delayed diagnoses and limited treatment options to gaps in awareness and collaboration. Through in-depth conversations with specialists across Canada, GRG Health uncovers the realities shaping HPP care in 2025 and the urgent need for education, teamwork, and faster insights to drive real change.

Metastatic melanoma was once a near-certain death sentence, but PD-1/PD-L1 inhibitors have rewritten the story. From survival rates once measured in months to long-term remission and renewed hope, immune checkpoint therapies like nivolumab and pembrolizumab are transforming cancer care and reshaping the future of oncology.